Rallybio Corporation (RLYB) DCF Valuation

Rallybio Corporation (RYB) DCF Valoración

US | Healthcare | Biotechnology | NASDAQ
Rallybio Corporation (RLYB) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Rallybio Corporation (RLYB) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Agilice su análisis y mejore la precisión con nuestra calculadora DCF (RYB)! Utilizando datos reales de Rallybio Corporation y supuestos personalizables, esta herramienta le permite pronosticar, analizar y valorar Rallybio como un inversor experimentado.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -17.4 -24.8 -45.4 -65.4 -72.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .1 .1 .2 .2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -17.4 -24.9 -45.5 -65.6 -72.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 19.5 140.2 175.3 169.0 109.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .9 1.6 .6 1.1 1.0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.2 -.1 -.3 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -17.6 -24.9 -47.0 -66.5 -72.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -16.9 -24.2 -48.2 -65.9 -72.5 -1.0 .0 .0 .0 .0
WACC, % 5.38 5.38 5.38 5.38 5.38 5.38 5.38 5.38 5.38 5.38
PV UFCF
SUM PV UFCF -.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -24
Equity Value 23
Diluted Shares Outstanding, MM 40
Equity Value Per Share 0.57

What You Will Receive

  • Comprehensive Financial Model: Rallybio Corporation’s actual data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate results as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Flexible and Reusable: Designed for adaptability, allowing for repeated application in detailed forecasting.

Key Features

  • Real-Life RLYB Data: Pre-filled with Rallybio Corporation’s historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures to fit your analysis.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
  • Scenario Testing: Develop various forecast scenarios to evaluate different valuation possibilities.
  • User-Friendly Design: Intuitive, organized, and crafted for both professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Rallybio Corporation (RLYB) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Rallybio Corporation’s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for Rallybio Corporation (RLYB)?

  • Comprehensive Tool: Integrates DCF, WACC, and various financial ratio analyses in one convenient package.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes Rallybio's intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide accurate and reliable starting points.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Rallybio Corporation (RLYB).

Who Should Use Rallybio Corporation (RLYB)?

  • Investors: Make informed investment choices with insights from a leading biotechnology firm.
  • Biotech Analysts: Utilize comprehensive data to streamline your research and analysis.
  • Healthcare Consultants: Adapt findings for client strategies or market assessments efficiently.
  • Biotech Enthusiasts: Enhance your knowledge of biopharmaceutical innovations and market trends.
  • Educators and Students: Leverage real-world case studies for learning in biotechnology and finance courses.

What the Template Contains

  • Pre-Filled Data: Contains Rallybio Corporation's (RLYB) historical financials and projections.
  • Discounted Cash Flow Model: An editable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A specific sheet for calculating WACC using custom inputs.
  • Key Financial Ratios: Assess Rallybio Corporation's profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visuals and tables summarizing essential valuation findings.

No products were found matching.